Pipeline
Relying on its proprietary technology platforms, UNIKE follows a differentiated pipeline strategy, focusing on areas with large clinical demand and outstanding market potential, while tackling difficult peptide and protein molecular design challenges to build competitive innovative drug candidates that address unmet clinical needs. Selected programs:
UNK-101
Type 2 Diabetes / Obesity
IND ENABLING
UNK-111
Obesity / Metabolic Syndrome
IND ENABLING
UNK-121
NASH / MASH
IND ENABLING
UNK-131
Growth Hormone Deficiency
IND ENABLING
UNK-141
Acromegaly & Oncology
IND ENABLING
UNK-201
Heart Failure
PCC
UNK-301
Viral Infection
PCC
UNK-311
Oncology & Anti-inflammation
PCC
UNK-151
Infertility / Assisted Reproduction
PCC
UNK-701
Pain Management
PCC
UNK-171
Short Bowel Syndrome
PCC
UNK-161
Osteoporosis
PCC
UNK-601
Age-related Macular Degeneration
PCC